Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1553827 | 0.85 | CA1 (0.44) | CA12CA1CA2CA9 | |
| SCHEMBL29433 | 0.83 | CA1 (0.42) | CA12CA1CA2CA9 | |
| SCHEMBL29432 | 0.83 | CA1 (0.42) | CA12CA1CA2CA9 | |
| SCHEMBL3889052 | 0.83 | CA1 (0.42) | CA12CA1CA2CA9 | |
| SCHEMBL27941342 | 0.80 | CA12 (0.30) | CA12CA1CA2CA9 | |
| SCHEMBL28076940 | 0.78 | CA1 (0.34) | CA12CA1CA2CA9 | |
| SCHEMBL27941341 | 0.74 | CA12 (0.37) | CA12CA1CA2CA9 | |
| SCHEMBL11387784 | 0.74 | CA1 (0.37) | CA12CA1CA2CA9 | |
| SCHEMBL2341384 | 0.72 | CA1 (0.37) | CA12CA1CA2CA9 | |
| SCHEMBL1014426 | 0.72 | CA1 (0.37) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6855848-B2 | Process for preparing bisallylboranes and nonaromatic boronic acids | CLARIANT GMBH (DE) | 2005-02-15 | — | — | US | disclosed |
| US-6706925-B2 | REACTING A DIENE WITH SODIUM BOROHYDRIDE IN THE PRESENCE OF AN OXIDANT AND IN AN INERT SOLVENT, WITH THE BORANE GENERATED IN SITU REACTING SELECTIVELY WITH THE DIENE TO FORM THE BIS(ALLYL)BORANE | CLARIANT GMBH (DE) | 2004-03-16 | — | — | US | disclosed |
| US-20040039233-A1 | Process for preparing bisallylboranes and nonaromatic boronic acids | CLARIANT GMBH | 2004-02-26 | — | — | US | disclosed |
| US-20030096995-A1 | Process for preparing bisallylboranes and nonaromatic boronic acids | CLARIANT GMBH | 2003-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096995-A1 | Process for preparing bisallylboranes and nonaromatic boronic acids | HBS1L, CBR1, RER1 | CA12 2038/4885CA1 730/4885CA2 1090/4885 |
| US-20040039233-A1 | Process for preparing bisallylboranes and nonaromatic boronic acids | HBS1L, CBR1, RER1 | CA12 2038/4885CA1 730/4885CA2 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.